Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Redeemable Convertible Preferred Stock [Member]	Total
Beginning balance (in shares) at Dec. 31, 2024					122,231,454
Beginning balance at Dec. 31, 2024					$ 768,566
Ending balance (in shares) at Mar. 31, 2025					122,231,454
Ending balance at Mar. 31, 2025					$ 768,566
Beginning balance (in shares) at Dec. 31, 2024	6,122,048
Beginning balance at Dec. 31, 2024	$ 6	$ 112,241	$ (772)	$ (970,959)		$ (859,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	130,813
Issuance of common stock upon exercise of stock options		578				578
Stock-based compensation expense		2,492				2,492
Foreign currency translation gain (loss)			(236)			(236)
Net loss				(32,345)		(32,345)
Ending balance (in shares) at Mar. 31, 2025	6,252,861
Ending balance at Mar. 31, 2025	$ 6	115,311	(1,008)	(1,003,304)		(888,995)
Beginning balance (in shares) at Dec. 31, 2024					122,231,454
Beginning balance at Dec. 31, 2024					$ 768,566
Ending balance (in shares) at Jun. 30, 2025					122,231,454
Ending balance at Jun. 30, 2025					$ 768,566
Beginning balance (in shares) at Dec. 31, 2024	6,122,048
Beginning balance at Dec. 31, 2024	$ 6	112,241	(772)	(970,959)		(859,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation gain (loss)						55
Net loss						(41,541)
Ending balance (in shares) at Jun. 30, 2025	6,389,444
Ending balance at Jun. 30, 2025	$ 6	118,416	(717)	(1,012,500)		(894,795)
Beginning balance (in shares) at Mar. 31, 2025					122,231,454
Beginning balance at Mar. 31, 2025					$ 768,566
Ending balance (in shares) at Jun. 30, 2025					122,231,454
Ending balance at Jun. 30, 2025					$ 768,566
Beginning balance (in shares) at Mar. 31, 2025	6,252,861
Beginning balance at Mar. 31, 2025	$ 6	115,311	(1,008)	(1,003,304)		(888,995)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	136,583
Issuance of common stock upon exercise of stock options		852				852
Stock-based compensation expense		2,253				2,253
Foreign currency translation gain (loss)			291			291
Net loss				(9,196)		(9,196)
Ending balance (in shares) at Jun. 30, 2025	6,389,444
Ending balance at Jun. 30, 2025	$ 6	118,416	(717)	(1,012,500)		$ (894,795)
Beginning balance (in shares) at Dec. 31, 2025	85,280,597					85,280,597
Beginning balance at Dec. 31, 2025	$ 85	1,388,737	(425)	(1,087,750)		$ 300,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	592,387
Issuance of common stock upon exercise of stock options	$ 1	3,341				3,342
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes (in shares)	28,740
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes		(473)				(473)
Issuance of common stock under employee stock purchase plan (in shares)	203,566
Issuance of common stock under employee stock purchase plan		3,288				3,288
Stock-based compensation expense		6,554				6,554
Unrealized loss on investments, net			(522)			(522)
Foreign currency translation gain (loss)			262			262
Net loss				(27,380)		(27,380)
Ending balance (in shares) at Mar. 31, 2026	86,105,290
Ending balance at Mar. 31, 2026	$ 86	1,401,447	(685)	(1,115,130)		$ 285,718
Beginning balance (in shares) at Dec. 31, 2025	85,280,597					85,280,597
Beginning balance at Dec. 31, 2025	$ 85	1,388,737	(425)	(1,087,750)		$ 300,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)						1,138,478
Unrealized loss on investments, net						$ (726)
Foreign currency translation gain (loss)						253
Net loss						$ (43,123)
Ending balance (in shares) at Jun. 30, 2026	86,717,381					86,717,381
Ending balance at Jun. 30, 2026	$ 87	1,411,411	(898)	(1,130,873)		$ 279,727
Beginning balance (in shares) at Mar. 31, 2026	86,105,290
Beginning balance at Mar. 31, 2026	$ 86	1,401,447	(685)	(1,115,130)		285,718
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	546,091
Issuance of common stock upon exercise of stock options	$ 1	3,225				3,226
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes (in shares)	66,000
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for taxes		(1,173)				(1,173)
Stock-based compensation expense		7,912				7,912
Unrealized loss on investments, net			(204)			(204)
Foreign currency translation gain (loss)			(9)			(9)
Net loss				(15,743)		$ (15,743)
Ending balance (in shares) at Jun. 30, 2026	86,717,381					86,717,381
Ending balance at Jun. 30, 2026	$ 87	$ 1,411,411	$ (898)	$ (1,130,873)		$ 279,727